Gonadal function following chemotherapy for childhood Hodgkin's disease

Medical and Pediatric Oncology

Volumn 27, Issue 2, 1996, Pages 74-78

  Mackie, E J ^a   Radford, M ^b   Shalet, S M ^a  

^a CHRISTIE HOSPITAL   (United Kingdom)

^b SOUTHAMPTON GENERAL HOSPITAL   (United Kingdom)

Author keywords

chemotherapy; gonadal toxicity; Hodgkin's disease

Indexed keywords

CHLORAMBUCIL; ESTRADIOL; FOLLITROPIN; GONADOTROPIN; LUTEINIZING HORMONE; PREDNISOLONE; PROCARBAZINE; TESTOSTERONE; VINBLASTINE;

ADOLESCENT; ARTICLE; CANCER COMBINATION CHEMOTHERAPY; CELL DAMAGE; ESTRADIOL BLOOD LEVEL; FEMALE; FOLLITROPIN BLOOD LEVEL; GERM LAYER; GONAD FUNCTION; GONADOTROPIN BLOOD LEVEL; HODGKIN DISEASE; HORMONE SUBSTITUTION; HUMAN; LEYDIG CELL; LUTEINIZING HORMONE BLOOD LEVEL; MAJOR CLINICAL STUDY; MALE; OVARY INSUFFICIENCY; PREGNANCY; PRIORITY JOURNAL; SCHOOL CHILD; TESTOSTERONE BLOOD LEVEL;

ADOLESCENT; ANTINEOPLASTIC COMBINED CHEMOTHERAPY PROTOCOLS; CHILD; CHLORAMBUCIL; ESTRADIOL; FEMALE; FOLLICLE STIMULATING HORMONE; HODGKIN DISEASE; HUMANS; LUTEINIZING HORMONE; MALE; OVARIAN FAILURE, PREMATURE; OVARY; PREDNISOLONE; PROCARBAZINE; PROGESTERONE; TESTIS; TESTOSTERONE; VINBLASTINE;

EID: 0029893274     PISSN: 00981532     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1096-911X(199608)27:2<74::AID-MPO2>3.0.CO;2-Q     Document Type: Article

References (24)

1. Radford M, Barrett A, Martin J: Treatment of Hodgkin's disease in children. Med Pediatr Oncol 19:400, 1991.
2. Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG: The effects of Hodgkin's disease and combination chemotherapy on gonadal function in the adult male. Cancer 49:418-422, 1982.
3. Waxman JHX, Terry YA, Wrigley PFM, Malpas JS, Rees LH, Besser GM, Lister TA: Gonadal function in Hodgkin's disease: Long-term follow-up of chemotherapy. Br Med J 285:1612-1613, 1982.
4. Kreuser ED, Xiros N, Hetzel WD, Heimpel H: Reproductive and endocrine gonadal capacity in patients treated with COPP chemotherapy for Hodgkin's disease. J Cancer Res Clin Oncol 113:260-266, 1987.
5. Chapman RM, Sutcliffe SB, Malpas JS: Male gonadal dysfunction in Hodgkin's disease. JAMA 245:1323-1328, 1981.
6. Whitehead E, Shalet SM, Morris Jones PH, Beardwell CG, Deakin DP: Gonadal function after combination chemotherapy for Hodgkin's disease in childhood. Arch Dis Child 47:287-291, 1982.
7. Sy Ortin TT, Shostak CA, Donaldson SS: Gonadal status and reproductive function following treatment for Hodgkin's disease in childhood: The Stanford experience. Int J Radiat Oncol Biol Phys 19:873-880, 1990.
8. Shafford EA, Kingston JE, Malpas JS, Plowman PN, Pritchard J, Savage MO, Eden OB: Testicular function following the treatment of Hodgkin's disease in childhood. Br J Cancer 68:1199-1204, 1993.
9. Bramswig JH, Heimes U, Heiermann E, Schlegel W, Nieschlag E, Schellong G: The effects of different cumulative doses of chemotherapy on testicular function Cancer 65:1298-1302, 1990.
10. Horning SJ, Hoppe RT, Kaplan HS, Rosenberg SA: Female reproductive potential after treatment for Hodgkin's disease. N Engl J Med 304:1381, 1981.
11. Chapman RM, Sutcliffe SB, Malpas JS: Cytotoxic-induced ovarian failure in women with Hodgkin's disease. JAMA 242:1877-1881, 1979.
12. Schilsky RL, Sherins RJ, Hubbard SM, Wesley MN, Young RC, DeVita VT: Long-term follow-up of ovarian function in women treated with MOPP chemotherapy for Hodgkin's disease. Am J Med 71:552-556, 1981.
13. Whitehead E, Shalet SM, Blackledge G, Todd I, Crowther D, Beardwell CG: The effect of combination chemotherapy on ovarian function in women treated for Hodgkin's disease. Cancer 52:988-993, 1983.
14. Stillman RJ, Schinfeld JS, Schiff I, Gelber RD, Greenberger J, Larson M, Jaffe N, Li PJ: Ovarian failure in long-term survivors of childhood malignancy. Am J Obstet Gynecol 139:62-66, 1981.
15. Byrne J, Mulvihill JJ, Myers MH, Connelly RR, Naughton MD, Krauss MR, Steinhorn SC, Hassinger DD, Austin DF, Bragg K, Holmes GF, Holmes FF, Latourette HB, Weyer PJ, Wister Meigs J, Teta J, Crook PHJW, Strong LC: Effects of treatment on fertility in long-term survivors of childhood or adolescent cancer. N Engl J Med 317:1315-1321, 1987.
16. Byrne J, Fears TR, Gail MH, Pee D, Connelly RR, Austin DF, Holmes GF, Holmes FF, Latourette HB, Wister Meigs J, Strong LCC, Myers MH, Mulvihill JJ: Early menopause in long-term survivors of cancer during adolescence. Am J Obstet Gynecol 166:788-793, 1992.
17. Spitz S: The histological effects of nitrogen mustards on human tumours and tissues. Cancer 1:383-398, 1948.
18. Louis J, Limarzi LR, Best W: Treatment of chronic granulocytic leukaemia with myleran. Arch Intern Med 97:299-308, 1956.
19. Watson AR, Rance CP, Bain J: Long term effects of cyclophosphamide on testicular function. Br Med J 291:1457-1460, 1985.
20. Guesry P, Lenoir G, Broyer M: Gonadal effects of chlorambucil given to prepubertal and pubertal boys for nephrotic syndrome. J Pediatr 92:299-303, 1970.
21. Holmes SJ, Whitehouse RW, Clark ST, Crowther DC, Adams JE, Shalet SM: Reduced bone mineral density in men following chemotherapy for Hodgkin's disease. Br J Cancer 70:371-375, 1994.
22. Clark ST, Radford JA, Crowther D, Swindell R, Shalet SM: Gonadal function following chemotherapy for Hodgkin's disease - a comparative study of MVPP and a seven drug hybrid regimen. J Clin Oncol 13:134-139, 1995.
23. Bramswig JH, Heiermann E, Heimes U, Schlegel W, Hanker JP, Schellong G: Ovarian function in 63 girls treated for Hodgkin's disease (HD) according to the West-German DAL-HD-78 and DAL-HD-82 therapy study. Med Pediatr Oncol 17:344, 1989.
24. Davies MC, Hall ML, Jacobs HS: Bone mineral loss in young women with amenorrhoea. Br Med J 301:790-793, 1990.